Core Laboratories NV (CLB)
Debt-to-equity ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | ||
---|---|---|---|---|
Long-term debt | US$ in thousands | 163,134 | 177,863 | 182,583 |
Total stockholders’ equity | US$ in thousands | 224,815 | 224,694 | 214,756 |
Debt-to-equity ratio | 0.73 | 0.79 | 0.85 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $163,134K ÷ $224,815K
= 0.73
The debt-to-equity ratio of Core Laboratories NV has been gradually decreasing over the three quarters, indicating a reducing reliance on debt to finance its operations and growth. This trend suggests that the company is becoming less leveraged and potentially lower risk for its investors. A decreasing debt-to-equity ratio may also indicate improved financial health and stability for Core Laboratories NV, as it implies a stronger equity position relative to its outstanding debt. Overall, the declining trend in the debt-to-equity ratio reflects a positive financial position for Core Laboratories NV.
Peer comparison
Dec 31, 2023